NIH T32 PIs and Administrators--Important Changes related to the Transition to xTRACT System

Weekly NIH Funding Opportunities and Notices

NIH Guide for Grants and Contracts
February 23, 2018
Table of Contents (TOC)
Web Version


Notices

    • Notice of Change to participation on PAR-18-514 " Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)"
      (NOT-OD-18-125) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    • Advance Notice of Transition to the xTRACT System for Preparing Research Training Data Tables
      (NOT-OD-18-133) National Institutes of Health
      Agency for Healthcare Research and Quality
    • Notice of Change to participation on PAR-18-512 "Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)"
      (NOT-OD-18-140) National Institutes of Health
    • Notice of Change to Instructions for Application Submission for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)"
      (NOT-OD-18-142) Office of Disease Prevention
    • Notice to Correct Activity Code Information For NIAAA PA-18-620 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional)
      (NOT-AA-18-004)
      National Institute on Alcohol Abuse and Alcoholism
    • Notice of Change to the Eligible Activity Codes for PA-16-013 "Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp)"
      (NOT-AT-18-006)
      National Center for Complementary and Integrative Health
    • Notice of expiration of PA-18-626 " NIDA Small Research Grant Program (R03 Clinical Trial Required)"
      (NOT-DA-18-008)
      National Institute on Drug Abuse
    • Request for Proposals (RFP) Notice: Toxicological Evaluations of Potential Medications
      (NOT-DA-18-062)
      National Institute on Drug Abuse
    • Notice of Pre-Application Webinar for PAR-17-341 National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)
      (NOT-GM-18-018)
      National Institute of General Medical Sciences
    • Notice of NIGMS Participation in PA-18-609 Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed)
      (NOT-GM-18-019)
      National Institute of General Medical Sciences
    • Notice of NIGMS Participation in PA-18-610 "Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed)"
      (NOT-GM-18-020)
      National Institute of General Medical Sciences
    • Notice of Technical Assistance Webinar for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed); RFA HL-19-001 and RFA HL-19-002
      (NOT-HL-18-598)
      National Heart, Lung, and Blood Institute
    • Notice of Availability of Administrative Supplements for Advancing Computational Modeling and Data Analytics Relevant to Mental Health
      (NOT-MH-18-023)
      National Institute of Mental Health
    • Notice of Intent to Publish a Funding Opportunity Announcement for SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
      (NOT-NS-18-046)
      National Institute of Neurological Disorders and Stroke

Requests for Applications

    • Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54)
      (RFA-OD-18-004)
      Office of Research on Women's Health
      National Institute on Aging
      National Institute on Alcohol Abuse and Alcoholism
      National Institute of Diabetes and Digestive and Kidney Diseases
      National Institute of Environmental Health Sciences
      National Institute of Mental Health
      Application Receipt Date(s): April 16 , 2018 apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
    • Limited Competition: NIH Coordination and Evaluation Center for Enhancing the Diversity of the NIH-Funded Workforce Program (U54 - Clinical Trial Not Allowed)
      (RFA-RM-18-005)
      Office of Strategic Coordination (Common Fund)
      National Institute of Mental Health
      Application Receipt Date(s): June 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Program Announcements

    • Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
      (PA-18-672)
      National Institutes of Health
      National Cancer Institute
      National Institute on Aging
      National Institute on Alcohol Abuse and Alcoholism
      National Institute of Arthritis and Musculoskeletal and Skin Diseases
      National Institute on Drug Abuse
      National Institute of Dental and Craniofacial Research
      National Institute of Environmental Health Sciences
      National Institute of General Medical Sciences
      National Institute of Nursing Research
      Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    • Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
      (PA-18-673)
      National Institutes of Health
      National Center for Complementary and Integrative Health
      National Cancer Institute
      National Eye Institute
      National Human Genome Research Institute
      National Institute on Aging
      National Institute on Alcohol Abuse and Alcoholism
      National Institute of Allergy and Infectious Diseases
      National Institute of Arthritis and Musculoskeletal and Skin Diseases
      Eunice Kennedy Shriver National Institute of Child Health and Human Development
      National Institute on Drug Abuse
      National Institute on Deafness and Other Communication Disorders
      National Institute of Dental and Craniofacial Research
      National Institute of Diabetes and Digestive and Kidney Diseases
      National Institute of Environmental Health Sciences
      National Institute of General Medical Sciences
      National Institute of Mental Health
      National Institute on Minority Health and Health Disparities
      National Institute of Neurological Disorders and Stroke
      National Library of Medicine
      Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
      Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    • Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp - Clinical Trial Optional)
      (PA-18-676)
      Office of Research on Women's Health
      National Cancer Institute
      National Eye Institute
      National Institute on Alcohol Abuse and Alcoholism
      National Institute of Allergy and Infectious Diseases
      National Institute of Arthritis and Musculoskeletal and Skin Diseases
      Eunice Kennedy Shriver National Institute of Child Health and Human Development
      National Institute on Drug Abuse
      National Institute on Deafness and Other Communication Disorders
      National Institute of Dental and Craniofacial Research
      National Institute of Diabetes and Digestive and Kidney Diseases
      National Institute of Mental Health
      National Institute of Nursing Research
      Office of the Director, NIH
      Application Receipt/Submission Date(s): April 16, 2018 by 5:00 PM local time of applicant organization.
    • Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
      (PA-18-677)
      National Cancer Institute
      Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    • Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
      (PA-18-678)
      National Cancer Institute
      Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
    • Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp Clilnical Trial Not Allowed)
      (PA-18-680)
      National Institute of Biomedical Imaging and Bioengineering
      Application Receipt/Submission Date(s): March 23, 2018; March 15, 2019; March 17, 2020 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
    • Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
      (PAR-18-669)
      Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
      Application Receipt/Submission Date(s): Not Applicable
    • U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
      (PAR-18-674)
      National Cancer Institute
      Application Receipt/Submission Date(s): June 13, 2018; October 11, 2018; June 13, 2019; October 11, 2019; June 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
    • U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
      (PAR-18-675)
      National Cancer Institute
      Application Receipt/Submission Date(s): June 13, 2018; October 11,2018; June 13, 2019; October 11, 2019; June 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
    • NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
      (PAR-18-679)
      National Institute of Allergy and Infectious Diseases
      Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.